Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
+5.52M
-
Total reported value, excl. options
-
$2.99B
-
Value change
-
+$222M
-
Put/Call ratio
-
0.08
-
Number of buys
-
95
-
Number of sells
-
-67
-
Price
-
$24.52
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2019
199 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2019.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 334M outstanding shares and own 36.46% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.9M shares), Avoro Capital Advisors LLC (10.8M shares), BlackRock Inc. (9.36M shares), VANGUARD GROUP INC (8.49M shares), FRANKLIN RESOURCES INC (7.05M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.02M shares), Consonance Capital Management LP (5.85M shares), FARALLON CAPITAL MANAGEMENT LLC (5.73M shares), ORBIMED ADVISORS LLC (5.55M shares), and GREAT POINT PARTNERS LLC (5.26M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.